TrialCancer2009

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.

Athanassios Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.